Glaucoma medical treatment as a predictor of XEN45 subconjunctival gel implant hypotensive efficacy.
Carmen-Dora Méndez-HernándezCarlos Palomino-BautistaRamón Torres-ImazPilar Peña-UrbinaLucía Perucho-GonzálezJulián García-FeijooPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2022)
One year after surgery, XEN45 gel implant significantly reduced IOP and number of topical medications with an adequate safety profile being both mainly influenced by the number of preoperative glaucoma treatments.